Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Descemet Stripping Endothelial Keratoplasty | 4 | 2024 | 10 | 1.840 |
Why?
|
| Lenses, Intraocular | 7 | 2022 | 277 | 1.400 |
Why?
|
| Lens Implantation, Intraocular | 8 | 2022 | 216 | 0.970 |
Why?
|
| Iris | 6 | 2022 | 44 | 0.950 |
Why?
|
| Sulfur Hexafluoride | 1 | 2024 | 4 | 0.860 |
Why?
|
| Endotamponade | 1 | 2024 | 7 | 0.860 |
Why?
|
| Anterior Chamber | 1 | 2024 | 33 | 0.850 |
Why?
|
| Fluorocarbons | 1 | 2024 | 59 | 0.820 |
Why?
|
| Eye Injuries, Penetrating | 3 | 2011 | 17 | 0.790 |
Why?
|
| Hyperopia | 4 | 2021 | 59 | 0.770 |
Why?
|
| Cornea | 6 | 2019 | 597 | 0.700 |
Why?
|
| Corneal Injuries | 4 | 2011 | 35 | 0.670 |
Why?
|
| Eye Injuries | 1 | 2020 | 42 | 0.650 |
Why?
|
| Blindness | 1 | 2020 | 76 | 0.650 |
Why?
|
| Endothelium, Corneal | 3 | 2010 | 28 | 0.620 |
Why?
|
| Tissue Adhesives | 2 | 2019 | 39 | 0.620 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 253 | 0.540 |
Why?
|
| Suture Techniques | 6 | 2015 | 188 | 0.530 |
Why?
|
| Keratomileusis, Laser In Situ | 4 | 2006 | 97 | 0.500 |
Why?
|
| Wound Healing | 2 | 2019 | 486 | 0.490 |
Why?
|
| Photorefractive Keratectomy | 5 | 2005 | 69 | 0.490 |
Why?
|
| Visual Acuity | 14 | 2024 | 709 | 0.480 |
Why?
|
| Artificial Lens Implant Migration | 2 | 2015 | 6 | 0.480 |
Why?
|
| Phacoemulsification | 2 | 2014 | 147 | 0.420 |
Why?
|
| Vision Disorders | 2 | 2014 | 219 | 0.390 |
Why?
|
| Conducted Energy Weapon Injuries | 1 | 2011 | 1 | 0.360 |
Why?
|
| Electric Injuries | 1 | 2011 | 3 | 0.360 |
Why?
|
| Electroshock | 1 | 2011 | 29 | 0.360 |
Why?
|
| Eye Foreign Bodies | 1 | 2011 | 11 | 0.360 |
Why?
|
| Corneal Diseases | 3 | 2024 | 96 | 0.320 |
Why?
|
| Sclera | 2 | 2014 | 45 | 0.300 |
Why?
|
| Amblyopia | 3 | 2005 | 25 | 0.280 |
Why?
|
| Descemet Membrane | 1 | 2007 | 10 | 0.270 |
Why?
|
| Tissue Donors | 1 | 2010 | 507 | 0.270 |
Why?
|
| Corneal Transplantation | 1 | 2007 | 45 | 0.260 |
Why?
|
| Postoperative Complications | 6 | 2015 | 3168 | 0.260 |
Why?
|
| Intraoperative Complications | 3 | 2015 | 164 | 0.260 |
Why?
|
| Anesthesia, Local | 1 | 2007 | 40 | 0.260 |
Why?
|
| Ectopia Lentis | 3 | 2015 | 12 | 0.210 |
Why?
|
| Refraction, Ocular | 3 | 2021 | 217 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2024 | 17562 | 0.200 |
Why?
|
| Anesthesia, General | 1 | 2003 | 123 | 0.190 |
Why?
|
| Humans | 35 | 2024 | 133492 | 0.190 |
Why?
|
| Lasers, Gas | 1 | 2022 | 7 | 0.190 |
Why?
|
| Varicose Veins | 1 | 2022 | 31 | 0.180 |
Why?
|
| Cataract Extraction | 2 | 2000 | 152 | 0.180 |
Why?
|
| Optics and Photonics | 2 | 2021 | 123 | 0.180 |
Why?
|
| Biometry | 1 | 2021 | 106 | 0.170 |
Why?
|
| Anisometropia | 3 | 2005 | 10 | 0.170 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 7191 | 0.170 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2000 | 51 | 0.160 |
Why?
|
| Cataract | 2 | 2015 | 169 | 0.160 |
Why?
|
| Laser Therapy | 1 | 2022 | 227 | 0.160 |
Why?
|
| Vitrectomy | 2 | 2018 | 91 | 0.150 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 7 | 0.150 |
Why?
|
| Middle Aged | 11 | 2024 | 29063 | 0.150 |
Why?
|
| Keratotomy, Radial | 2 | 1996 | 31 | 0.150 |
Why?
|
| Female | 20 | 2024 | 71527 | 0.150 |
Why?
|
| Candida glabrata | 1 | 2018 | 20 | 0.140 |
Why?
|
| Fibrin | 1 | 2018 | 64 | 0.140 |
Why?
|
| Endophthalmitis | 1 | 2018 | 68 | 0.140 |
Why?
|
| Eye Infections, Fungal | 1 | 2018 | 73 | 0.130 |
Why?
|
| Myopia | 4 | 2006 | 133 | 0.130 |
Why?
|
| Candidiasis | 1 | 2018 | 138 | 0.130 |
Why?
|
| Refractive Surgical Procedures | 1 | 1996 | 45 | 0.120 |
Why?
|
| Lasers, Excimer | 5 | 2005 | 69 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 272 | 0.120 |
Why?
|
| Laser Coagulation | 1 | 1996 | 129 | 0.120 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2014 | 30 | 0.110 |
Why?
|
| Aged | 5 | 2024 | 21568 | 0.110 |
Why?
|
| Anterior Eye Segment | 1 | 2014 | 25 | 0.110 |
Why?
|
| Male | 16 | 2024 | 65634 | 0.110 |
Why?
|
| Aphakia, Postcataract | 2 | 2015 | 18 | 0.100 |
Why?
|
| Surgical Flaps | 3 | 2006 | 192 | 0.100 |
Why?
|
| Child, Preschool | 10 | 2015 | 14896 | 0.090 |
Why?
|
| Trypan Blue | 1 | 2010 | 4 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2015 | 13088 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 3042 | 0.080 |
Why?
|
| Child | 11 | 2015 | 25875 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 61 | 0.070 |
Why?
|
| Acanthamoeba Keratitis | 1 | 2008 | 16 | 0.070 |
Why?
|
| Corneal Stroma | 2 | 2003 | 80 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 196 | 0.070 |
Why?
|
| Lidocaine | 1 | 2007 | 46 | 0.070 |
Why?
|
| Safety | 3 | 2004 | 217 | 0.060 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 89 | 0.060 |
Why?
|
| Contact Lenses | 4 | 2008 | 42 | 0.060 |
Why?
|
| Keratitis | 3 | 1991 | 107 | 0.060 |
Why?
|
| Chlorhexidine | 1 | 1984 | 49 | 0.060 |
Why?
|
| Depth Perception | 1 | 2004 | 13 | 0.060 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1984 | 71 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 5451 | 0.050 |
Why?
|
| Adolescent | 6 | 2015 | 20587 | 0.050 |
Why?
|
| Eye | 1 | 1984 | 237 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2022 | 6584 | 0.050 |
Why?
|
| Macular Degeneration | 1 | 2004 | 127 | 0.050 |
Why?
|
| Argon | 1 | 2022 | 1 | 0.050 |
Why?
|
| Infant | 3 | 2015 | 13254 | 0.050 |
Why?
|
| Photophobia | 1 | 2022 | 9 | 0.050 |
Why?
|
| Dry Eye Syndromes | 1 | 2006 | 287 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 139 | 0.050 |
Why?
|
| Epithelium, Corneal | 1 | 2003 | 171 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 159 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2003 | 279 | 0.040 |
Why?
|
| Corneal Topography | 3 | 2005 | 154 | 0.040 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2018 | 6 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2018 | 142 | 0.030 |
Why?
|
| Antifungal Agents | 2 | 2018 | 306 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 1997 | 56 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 1997 | 169 | 0.030 |
Why?
|
| Quality of Life | 2 | 2022 | 2160 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1997 | 358 | 0.030 |
Why?
|
| Time Factors | 4 | 2014 | 6545 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 1344 | 0.030 |
Why?
|
| Adult | 7 | 2008 | 31765 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 663 | 0.020 |
Why?
|
| Chickenpox | 1 | 1991 | 22 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2005 | 1463 | 0.020 |
Why?
|
| Physicians, Family | 1 | 1990 | 38 | 0.020 |
Why?
|
| Benzamidines | 1 | 2008 | 10 | 0.020 |
Why?
|
| Vision, Binocular | 1 | 2008 | 29 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 2008 | 42 | 0.020 |
Why?
|
| Mycoses | 1 | 1988 | 117 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 1990 | 167 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2008 | 110 | 0.020 |
Why?
|
| Fluorophotometry | 1 | 2006 | 30 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11758 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1999 | 8633 | 0.010 |
Why?
|
| Enterobacter | 1 | 1984 | 15 | 0.010 |
Why?
|
| Premedication | 1 | 1984 | 42 | 0.010 |
Why?
|
| Staphylococcus epidermidis | 1 | 1984 | 40 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1997 | 2088 | 0.010 |
Why?
|
| Ophthalmic Solutions | 1 | 1984 | 90 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 238 | 0.010 |
Why?
|
| Rabbits | 1 | 1984 | 709 | 0.010 |
Why?
|
| Visual Fields | 1 | 2004 | 146 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 475 | 0.010 |
Why?
|
| Risk Factors | 2 | 2008 | 10967 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2004 | 430 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1984 | 836 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2003 | 359 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 2678 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 3448 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 937 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 3393 | 0.010 |
Why?
|
| Pursuit, Smooth | 1 | 1997 | 11 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1997 | 29 | 0.010 |
Why?
|
| Saccades | 1 | 1997 | 21 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1997 | 465 | 0.010 |
Why?
|
| Aorta | 1 | 1997 | 548 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1997 | 463 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1997 | 543 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 1989 | 49 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1990 | 244 | 0.000 |
Why?
|
| Gram-Negative Bacteria | 1 | 1989 | 74 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 342 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1989 | 328 | 0.000 |
Why?
|
| Mass Screening | 1 | 1990 | 833 | 0.000 |
Why?
|
| Animals | 1 | 1984 | 36120 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1991 | 2592 | 0.000 |
Why?
|